Evidence map›Paper›PMID 41154411›Full record

ArticleCancers2025

Reply to Taal et al. Comment on "Iasella et al. Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour.

Maria Pia Iasella, Dries Ruttens, Daphne Hompes, Vincent Vandecaveye, Raf Sciot, Christophe Deroose, Thomas Douchy, Thomas Decramer, Sandra Jacobs, Ellen Denayer and 3 more

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Maria Pia IasellaCentre for Human Genetics, University Hospitals Leuven, KU Leuven, 3000 Leuven, Belgium.
Dries RuttensDepartment of Paediatric Oncology, University Hospitals Leuven, 3000 Leuven, Belgium.
Daphne HompesDepartment of Surgical Oncology, University Hospitals Leuven, 3000 Leuven, Belgium.
Vincent VandecaveyeRadiology Department, University Hospitals Leuven, 3000 Leuven, Belgium.
Raf SciotDepartment of Pathology, University Hospitals Leuven, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0003-2244-5839
Christophe DerooseNuclear Medicine, University Hospitals Leuven, and Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-6080-1577
Thomas DouchyDepartment of Surgical Oncology, University Hospitals Leuven, 3000 Leuven, Belgium.ORCID 0000-0001-9972-644X
Thomas DecramerDepartment of Neurosurgery, University Hospitals Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-2585-581X
Sandra JacobsDepartment of Paediatric Oncology, University Hospitals Leuven, 3000 Leuven, Belgium.
Ellen DenayerCentre for Human Genetics, University Hospitals Leuven, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0001-6478-181X
Frank Van CalenberghDepartment of Neurosurgery, University Hospitals Leuven, 3000 Leuven, Belgium.
Eric LegiusCentre for Human Genetics, University Hospitals Leuven, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0003-2410-6996
Hilde BremsCentre for Human Genetics, University Hospitals Leuven, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-0325-4060

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We would like to sincerely thank Dr [...].

Identifiers

PMID41154411
PMCPMC12563037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.